Digital repository of Slovenian research organisations

Show document
A+ | A- | SLO | ENG

Title:Vloga radioloških in nuklearnomedicinskih slikovnih preiskovalnih metod pri karcinomu nosnega dela žrela
Authors:ID Jakič, Maja (Author)
ID Šurlan Popović, Katarina (Author)
Files:.pdf PDF - Presentation file, download (1,81 MB)
MD5: D409718D8C65B3CB9AC17F4DBDDBF1B8
Typology:1.02 - Review Article
Organization:Logo OI - Institute of Oncology
Keywords:karciom, nosno žrelo, radiološka diagnostika, računalniška tomografija, zdravljenje
Year of publishing:2015
Publication status in journal:Published
Article version:Publisher's version of article
Number of pages:str. 22-26, 36
Numbering:Letn. 19, št. 1
PID:20.500.12556/DiRROS-8157 New window
UDC:radiološka diagnostika
ISSN on article:1408-1741
COBISS.SI-ID:2822572 New window
Copyright:by Authors
Publication date in DiRROS:19.03.2018
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija : strokovni časopis za zdravnike
Shortened title:Onkologija
Publisher:Onkološki inštitut
COBISS.SI-ID:65324032 New window


License:CC BY 4.0, Creative Commons Attribution 4.0 International
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:03.01.2018

Secondary language

Title:The role of radiological and nuclear medicine imaging methods in nasopharyngeal carcinoma
Abstract:Nasopharyngeal carcinoma (NPC) is a rare disease in the Slovenian population. Treatment depends also on the TNM stage of the carcinoma, which is determined also with the help of radiologic and nuclear medicine imaging methods. The radiologic imaging examination method of choice for detecting NPC and lymph node metastases is MRI, whereas spreading of NPC to bone structures is best shown using CT. To continue, PET-CT is the method of choice for detecting distant metastases and disease recurrence 3 to 6 months after completed treatment.